Peer-reviewedCC BYFrontiers in endocrinology16 Oct 2026

Pancreatic and biliary safety signals of GLP-1 receptor agonists and tirzepatide: a disproportionality analysis of FAERS reports

Yuanbin Wu¹
Ke Li¹
Yuhong Wang¹
Zike Chen²
Min Shi²
Jiawei Zhao²

¹Department of Emergency Medicine, The Seventh Medical Center, Chinese PLA General Hospital , ,
²Department of Gastroenterology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine , ,

Beyond glycemic control: cardiovascular and kidney benefits of GLP-1 receptor agonists and the dual GIP/GLP-1 receptor agonist tirzepatide: a narrative review
Filip Kierzkowski, Wiktoria Skrzypek, Wiesław Bryl +2
Frontiers in Endocrinology16 Oct 2026Peer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefEurope PMCPMC
Biliary and Pancreatic Safety of Incretin-Based Therapies in Obesity and Type 2 Diabetes: A Propensity-Matched Real-World Comparison of Tirzepatide, Semaglutide, and DPP-4 Inhibitors
Wissam Ghusn, Sasha-Jane Abi-Aad, Maria Daniela Hurtado
Journal of Clinical Medicine1 Oct 2026Peer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefEurope PMC
GLP-1 receptor agonists counteract the detrimental effects of pasireotide on pancreatic beta-cell function and survival
Giuseppina Biondi, Nicola Marrano, Martina Rella +16
Scientific Reports12 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaCrossref
Neuropsychiatric Safety of GLP-1 Receptor Agonists and Tirzepatide in Adults with Type 2 Diabetes Mellitus or Obesity.
Het Tushar Jani, Helisse Levine, Abhiraj Patel +2
Rambam Maimonides medical journal26 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
Tirzepatide safety in EudraVigilance: descriptive and disproportionality analysis of preferred terms related to suboptimal treatment outcomes and drug-use-related issues
Ioana Rada Popa Ilie, Steliana Ghibu, Anca Butuca +6
BMJ Open1 Oct 2026Peer-reviewedCC BY-NC 4.0Pharmacology & toxicologyCrossref

Cite

BibTeX

@article{wu2026pancreatic,
  title = {{Pancreatic and biliary safety signals of GLP-1 receptor agonists and tirzepatide: a disproportionality analysis of FAERS reports}},
  author = {Yuanbin Wu and Ke Li and Yuhong Wang and Zike Chen and Min Shi and Jiawei Zhao},
  journal = {Frontiers in endocrinology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13654742},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Pancreatic and biliary safety signals of GLP-1 receptor agonists and tirzepatide: a disproportionality analysis of FAERS reports
AU  - Yuanbin Wu
AU  - Ke Li
AU  - Yuhong Wang
AU  - Zike Chen
AU  - Min Shi
AU  - Jiawei Zhao
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in endocrinology
UR  - https://europepmc.org/article/PMC/PMC13654742
SN  - 1664-2392
ER  -

Related

Cite